Could This Tiny Device Help You Make an Extra $30k a Year?

I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.

Click here to see the details because I believe a lot of people will get rich.

Bernei B. Berry, III net worth and biography

Bernei Berry, III Biography and Net Worth

Director of OrthoPediatrics

Bernie Berry is the former President and owner of Carr Metal Products, Inc. (CMP), a world‐wide leader in the design, development, and manufacturing of precision sheet metal and plastic fabrications. Mr. Berry joined CMP, a firm his father co‐founded, in 1975. He was appointed president in 1985 where he would direct the company’s activities and growth strategies. Among his many accomplishments, Mr. Berry developed an environment of innovation and superior product development by embracing new technologies and advanced manufacturing principals. Carr Metal Products was acquired by Precimed Group, a leading technology‐driven supplier to the orthopedic industry in 2006, which resulted in Mr. Berry’s company being renamed Precimed CMP. In 2008, Precimed was purchased by Greatbatch, Inc., a leading designer and manufacturer of high quality, innovative products and systems to customers in the cardiac, neuromodulation, orthopedics and commercial markets. Mr. Berry is a graduate of Purdue University and remains an active consultant and advisor to the medical device industry.

What is Bernei B. Berry, III's net worth?: The estimated net worth of Bernei B. Berry, III is at least $552,780.98 as of May 6th, 2021. Mr. Berry, III owns 24,481 shares of OrthoPediatrics stock worth more than $552,781 as of December 24th. This net worth evaluation does not reflect any other assets that Mr. Berry, III may own. Learn More about Bernei B. Berry, III's net worth.
How do I contact Bernei B. Berry, III?: The corporate mailing address for Mr. Berry, III and other OrthoPediatrics executives is 2850 Frontier Drive, Warsaw IN, 46582. OrthoPediatrics can also be reached via phone at (574) 268-6379 and via email at [email protected]. Learn More on Bernei B. Berry, III's contact information.
Has Bernei B. Berry, III been buying or selling shares of OrthoPediatrics?: Bernei B. Berry, III has not been actively trading shares of OrthoPediatrics during the last ninety days. Most recently, Bernie B. Berry III sold 100 shares of the business's stock in a transaction on Monday, August 9th. The shares were sold at an average price of $72.00, for a transaction totalling $7,200.00. Following the completion of the sale, the director now directly owns 23,481 shares of the company's stock, valued at $1,690,632. Learn More on Bernei B. Berry, III's trading history.
Who are OrthoPediatrics' active insiders?: OrthoPediatrics' insider roster includes Bernei Berry, III (Director), Stephen Burns (Director), Fred Hite (CFO), Marie Infante (Director), Gregory Odle (EVP), Jennifer Pritzker (Major Shareholder), Terry Schlotterback (Director), and Mark Throdahl (CEO). Learn More on OrthoPediatrics' active insiders.
Are insiders buying or selling shares of OrthoPediatrics?: In the last twelve months, insiders at the sold shares 7 times. They sold a total of 27,253 shares worth more than $770,374.68. The most recent insider tranaction occured on August, 21st when General Counsel Daniel J Gerritzen sold 10,000 shares worth more than $293,000.00. Insiders at OrthoPediatrics own 31.8% of the company. Learn More about insider trades at OrthoPediatrics.
Information on this page was last updated on 8/21/2024.

Bernei B. Berry, III Insider Trading History at OrthoPediatrics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/9/2021	Sell	100	$72.00	$7,200.00	23,481
8/2/2021	Sell	2,000	$66.60	$133,200.00
6/15/2021	Sell	300	$64.54	$19,362.00
5/6/2021	Sell	3,209	$60.00	$192,540.00	24,481
2/25/2021	Sell	699	$57.00	$39,843.00	32,481
2/18/2021	Sell	4,000	$54.07	$216,280.00	36,481
1/27/2021	Sell	3,136	$51.73	$162,225.28	40,481
5/21/2020	Sell	1,000	$45.71	$45,710.00	43,810

Bernei B. Berry, III Buying and Selling Activity at OrthoPediatrics

OrthoPediatrics Company Overview

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Today's Range

Now: $22.58

$22.40

$22.76

50 Day Range

MA: $25.19

$21.92

$30.95

2 Week Range

Now: $22.58

$21.02

$36.23

Volume

158,919 shs

Average Volume

176,376 shs

Market Capitalization

$546.80 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.14